Status:
COMPLETED
Ki67 Proliferation Index of Pancreatic Neuroendocrine Neoplasia
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Neuroendocrine Tumors
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective, monocentric study involving 50 patients with pancreatic neuroendocrine neoplasia resected between January 2008 and June 2020 at Paoli Calmettes Institute. The primary objecti...
Eligibility Criteria
Inclusion
- Patients with resection of pancreatic neuroendocrine neoplasia by surgery at Paoli Calmettes Institute between January 2008 and June 2020
- Patients who had a pre-surgical evaluation of Ki67 on micro-biopsy equipment obtained by echo-endoscopy.
Exclusion
- Patient with a mixed tumor of the pancreas.
- Patient with a pancreas tumor composed of several nodules of similar size without a main mass and for which it is not possible to determine the biopsied nodule during echo-endoscopy.
- Initial micro-biopsy in a private pathology laboratory
- Initial subechoendoscopic puncture cytology only (Ki67 not possible)
- No initial micro-biopsy and surgery
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04753229
Start Date
January 1 2008
End Date
October 1 2020
Last Update
February 18 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.